MASLD and sarcopenia research (2012–2025): a multi-database bibliometric analysis
Frontiers in Nutrition · 12.06.2026 · 13
DOI: 10.3389/fnut.2026.1834112 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Nutrition, online erschienen am 12.06.2026. Verfasst von Keyan Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
MASLD and sarcopenia share common pathophysiological mechanisms, including insulin resistance and chronic inflammation, and their coexistence has been associated with increased risks of hepatic fibrosis, cardiovascular events, and all-cause mortality. Mapping research trends and nutrition-related implications along the liver–muscle axis may help inform precision nutrition strategies. Materials and methods English-language original articles and reviews published from January 2012 to December 2025 were retrieved from the Web of Science Core Collection and Scopus databases. A total of 701 unique publications were included. Bibliometric analyses, including descriptive statistics, collaboration network analysis, co-citation analysis, and keyword burst detection, were performed using the R package bibliometrix, CiteSpace, and VOSviewer. BERTopic modeling was applied to identify latent semantic themes and their temporal evolution. Relevant prospective cohort studies from PubMed were also reviewed to provide contextual evidence on longitudinal associations between muscle-related parameters and MASLD outcomes.
Results
The field grew at an average annual rate of 36.6%, with China, South Korea, and the United States forming the core collaborative network; South Korean authors showed particularly high productivity and influence. The research focus shifted from molecular mechanisms to clinical phenotyping, risk prediction, and intervention-related topics. BERTopic modeling identified three emerging themes: sarcopenia–fibrosis risk, lipid metabolism with lifestyle interventions, and cardiometabolic comorbidity management. The prospective cohort studies suggested that low muscle mass and impaired muscle function were associated with a higher risk of MASLD onset or progression (HR 1.18–7.96), consistent with previously proposed mechanisms, including lipotoxicity, systemic inflammation, and gut–liver–muscle axis dysregulation.
Conclusion
Research on MASLD and sarcopenia has progressively shifted from descriptive and mechanistic studies toward early fibrosis risk prediction, lifestyle-based interventions, and integrated metabolic management. Standardized muscle assessment and further investigation of the liver–muscle axis are needed to support precision nutrition strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Zitieren
APA
Gao, K., Xun, L., Hao, S., An, M., Zuo, L., Wang, J., Wang, Y., & He, J. (2026). MASLD and sarcopenia research (2012–2025): a multi-database bibliometric analysis. Frontiers in Nutrition, 13. https://doi.org/10.3389/fnut.2026.1834112
Vancouver
Gao K, Xun L, Hao S, An M, Zuo L, Wang J, et al. MASLD and sarcopenia research (2012–2025): a multi-database bibliometric analysis. Frontiers in Nutrition. 2026;13. doi:10.3389/fnut.2026.1834112
BibTeX
@article{Gao2026,
author = {Gao, Keyan and Xun, Liwen and Hao, Shalei and An, Min and Zuo, Lingfeng and Wang, Jiayu and Wang, Ying and He, Junhua},
title = {MASLD and sarcopenia research (2012–2025): a multi-database bibliometric analysis},
journal = {Frontiers in Nutrition},
year = {2026},
volume = {13},
doi = {10.3389/fnut.2026.1834112}
}
EUVIMED